Therapeutic potential of IL-27 in systemic lupus erythematosus

Author： Pan Hai-Feng Tao Jin-Hui Ye Dong-Qing

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.5, 2010-05, pp. : 479-484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Targets of Misguided T Cells in Systemic Lupus Erythematosus

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 295-298

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy

By Pego-Reigosa Jose Maria Isenberg David A

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 1, 2008-01 ,pp. : 31-41

Informa Healthcare

Access to resources Recommend Favorite

Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1261-1269

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Action and Therapeutic Activity

Current Medicinal Chemistry, Vol. 19, Iss. 3, 2012-01 ,pp. : 438-453

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Interventions of Tissue Specific Autoimmune Onset in Systemic Lupus Erythematosus

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 15, 2017-09 ,pp. : 1418-1424

Bentham Science Publishers

Access to resources Recommend Favorite